fbpx
Medical Innovation Exchange

ASCO: Genentech touts bispecific data for DLBCL calling it 'groundbreaking' for heavily pretreated patients

https://www.fiercebiotech.com/biotech/genentech-wants-offer-easier-treatment-path-lymphoma-patients-whove-been-through-it-all

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.